These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34975223)

  • 1. Evaluation of bexagliflozin in cats with poorly regulated diabetes mellitus.
    Benedict SL; Mahony OM; McKee TS; Bergman PJ
    Can J Vet Res; 2022 Jan; 86(1):52-58. PubMed ID: 34975223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and effectiveness of the sodium-glucose cotransporter inhibitor bexagliflozin in cats newly diagnosed with diabetes mellitus.
    Hadd MJ; Bienhoff SE; Little SE; Geller S; Ogne-Stevenson J; Dupree TJ; Scott-Moncrieff JC
    J Vet Intern Med; 2023; 37(3):915-924. PubMed ID: 37148170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of serum fructosamine and blood glycosylated hemoglobin concentrations for assessment of glycemic control in cats with diabetes mellitus.
    Elliott DA; Nelson RW; Reusch CE; Feldman EC; Neal LA
    J Am Vet Med Assoc; 1999 Jun; 214(12):1794-8. PubMed ID: 10382020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of feline diabetes mellitus using an alpha-glucosidase inhibitor and a low-carbohydrate diet.
    Mazzaferro EM; Greco DS; Turner AS; Fettman MJ
    J Feline Med Surg; 2003 Jun; 5(3):183-9. PubMed ID: 12765629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of protamine zinc insulin for treatment of diabetes mellitus in cats.
    Nelson RW; Lynn RC; Wagner-Mann CC; Michels GM
    J Am Vet Med Assoc; 2001 Jan; 218(1):38-42. PubMed ID: 11149712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pasireotide Long-Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism.
    Gostelow R; Scudder C; Keyte S; Forcada Y; Fowkes RC; Schmid HA; Church DB; Niessen SJ
    J Vet Intern Med; 2017 Mar; 31(2):355-364. PubMed ID: 28145031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 24-week, randomized, double-blind, active-controlled clinical trial comparing bexagliflozin with sitagliptin as an adjunct to metformin for the treatment of type 2 diabetes in adults.
    Halvorsen YD; Lock JP; Zhou W; Zhu F; Freeman MW
    Diabetes Obes Metab; 2019 Oct; 21(10):2248-2256. PubMed ID: 31161692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of diet on glucose control in cats with diabetes mellitus treated with twice daily insulin glargine.
    Hall TD; Mahony O; Rozanski EA; Freeman LM
    J Feline Med Surg; 2009 Feb; 11(2):125-30. PubMed ID: 18835801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive 50-week evaluation of glipizide administration in 50 cats with previously untreated diabetes mellitus.
    Feldman EC; Nelson RW; Feldman MS
    J Am Vet Med Assoc; 1997 Mar; 210(6):772-7. PubMed ID: 9074678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum fructosamine concentration as an index of glycemia in cats with diabetes mellitus and stress hyperglycemia.
    Crenshaw KL; Peterson ME; Heeb LA; Moroff SD; Nichols R
    J Vet Intern Med; 1996; 10(6):360-4. PubMed ID: 8947867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose concentrations after insulin-induced hypoglycemia and glycemic variability in healthy and diabetic cats.
    Zini E; Salesov E; Dupont P; Moretto L; Contiero B; Lutz TA; Reusch CE
    J Vet Intern Med; 2018 May; 32(3):978-985. PubMed ID: 29603806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Field safety and efficacy of protamine zinc recombinant human insulin for treatment of diabetes mellitus in cats.
    Nelson RW; Henley K; Cole C;
    J Vet Intern Med; 2009; 23(4):787-93. PubMed ID: 19566845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 12-week, randomized, double-blind, placebo-controlled, four-arm dose-finding phase 2 study evaluating bexagliflozin as monotherapy for adults with type 2 diabetes.
    Halvorsen YD; Walford G; Thurber T; Russell H; Massaro M; Freeman MW
    Diabetes Obes Metab; 2020 Apr; 22(4):566-573. PubMed ID: 31749238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of serum fructosamine concentration as an index of blood glucose control in cats with diabetes mellitus.
    Kaneko JJ; Kawamoto M; Heusner AA; Feldman EC; Koizumi I
    Am J Vet Res; 1992 Oct; 53(10):1797-801. PubMed ID: 1456523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Effectiveness of Bexagliflozin in Patients With Type 2 Diabetes Mellitus and Stage 3a/3b CKD.
    Allegretti AS; Zhang W; Zhou W; Thurber TK; Rigby SP; Bowman-Stroud C; Trescoli C; Serusclat P; Freeman MW; Halvorsen YC
    Am J Kidney Dis; 2019 Sep; 74(3):328-337. PubMed ID: 31101403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral hypoglycemics in cats with diabetes mellitus.
    Palm CA; Feldman EC
    Vet Clin North Am Small Anim Pract; 2013 Mar; 43(2):407-15. PubMed ID: 23522179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glargine insulin and high-protein-low-carbohydrate diet in cats with diabetes mellitus.
    Boari A; Aste G; Rocconi F; Dalessandri A; Vita S
    Vet Res Commun; 2008 Sep; 32 Suppl 1():S243-5. PubMed ID: 18685984
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin glargine 300 U/ml for the treatment of feline diabetes mellitus.
    Linari G; Fleeman L; Gilor C; Giacomelli L; Fracassi F
    J Feline Med Surg; 2022 Feb; 24(2):168-176. PubMed ID: 34009061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin detemir treatment in diabetic cats in a practice setting.
    Hoelmkjaer KM; Spodsberg EM; Bjornvad CR
    J Feline Med Surg; 2015 Feb; 17(2):144-51. PubMed ID: 24938314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the oral antihyperglycemic drug metformin in normal and diabetic cats.
    Nelson R; Spann D; Elliott D; Brondos A; Vulliet R
    J Vet Intern Med; 2004; 18(1):18-24. PubMed ID: 14765727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.